Interventional device developer Boston Scientific of Natick, MA, has made a $15 million investment in Rubicon Medical, a Salt Lake City-based developer and manufacturer of interventional vascular medical devices and products. Coupled with the common shares it received in its July 2003 investment of $2 million, Boston Scientific now owns a total of 18% of Rubicon’s fully diluted equity.
By AuntMinnie.com staff writersOctober 30, 2003
Related Reading
Q3 gains reported at Boston Scientific, October 22, 2003
FDA sets date to review Boston Scientific stent, September 16, 2003
Boston Scientific releases Taxus clinical results, September 16, 2003
Boston Scientific’s Taxus stent receives Canadian approval, September 12, 2003
Boston Scientific, CryoVascular form alliance, September 11, 2003
Copyright © 2003 AuntMinnie.com
